Posted in | News | Nanomedicine | Nanomaterials

CWRU Researcher to Receive Fund for Developing Nanotechnology-Based Platelets

A Case Western Reserve University researcher will receive a $2.3 million New Innovator Award today to further develop and broaden the uses of synthetic platelets and the technology that makes them work.

Erin Lavik, associate professor of biomedical engineering, uses nanotechnology to build platelets of biodegradable polymers, which link with natural platelets to stem bleeding faster.

She and fellow researchers initially pursued the technology after seeing the damage and death tolls among soldiers who received traumatic brain injuries in Afghanistan and Iraq.

The award, presented by the National Institutes of Health, is designed specifically to support unusually creative new investigators with highly innovative research ideas at an early stage of their career.

"It will provide a wonderful foundation for supporting my students as we pursue this research," Lavik said.

Lavik's lab will continue testing and fine-tuning the artificial platelets toward use in people suffering all kinds of traumatic injuries. She also plans to develop new modes of drug delivery based on the system the synthetic platelets use to home in and lock onto clotting natural platelets.

"NIH is pleased to be supporting early-stage investigators from across the country who are taking considered risks in a wide range of areas in order to accelerate research," said Francis S. Collins, M.D., Ph.D., director of the National Institutes. "We look forward to the results of their work."

Source: http://www.case.edu/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.